Diagnosing Active TB Disease in Patients with Known Latent TB Infection

Key Principles

• The American College of Radiology recommends that a normal chest X-ray does not exclude active TB, especially in immunocompromised patients 4
• The Infectious Diseases Society of America states that TST and IGRA tests cannot differentiate between latent TB infection and active TB disease, and should not be relied upon for diagnosis 1

Diagnostic Algorithm for Active TB Disease

• The Centers for Disease Control and Prevention recommend collecting three sputum samples on different days to maximize diagnostic sensitivity, with a minimum 3 mL volume and optimal 5-10 mL per specimen 1
• The World Health Organization suggests performing both AFB smear and mycobacterial culture on all specimens, with mycobacterial culture being the gold standard for diagnosis 1

Special Considerations for Immunocompromised Patients

• The Journal of the American College of Radiology notes that HIV-infected patients may present atypically with mediastinal lymphadenopathy alone or deceptively normal chest radiographs, and recommends a lower threshold for CT imaging in severely immunocompromised hosts 4

Critical Pitfalls to Avoid

• The Clinical Infectious Diseases journal advises against repeating TST or IGRA testing, as these will remain positive from prior LTBI and provide no diagnostic value for active disease 1
• The American College of Radiology warns against assuming a normal chest X-ray excludes TB, and recommends proceeding with sputum collection if clinical suspicion remains high, especially in immunocompromised patients 4

Drug Susceptibility Testing

• The Infectious Diseases Society of America recommends performing rapid molecular drug susceptibility testing for rifampin on respiratory specimens from patients who are AFB smear-positive or NAAT-positive and meet certain criteria, such as prior TB treatment history or being born in or lived ≥1 year in a country with high TB incidence 1